Sinopharm Group Co (HKSE:01099) Change In Other Working Capital : HK$13,325 Mil (TTM As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Sinopharm Group Co Change In Other Working Capital?

Sinopharm Group Co's Change In Other Working Capital for the quarter that ended in Dec. 2024 was HK$-4,606 Mil. It means Sinopharm Group Co's Other Working Capital declined by HK$4,606 Mil from Jun. 2024 to Dec. 2024 .

Sinopharm Group Co's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was HK$13,177 Mil. It means Sinopharm Group Co's Other Working Capital increased by HK$13,177 Mil from Dec. 2023 to Dec. 2024 .

Sinopharm Group Co Change In Other Working Capital Historical Data

The historical data trend for Sinopharm Group Co's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Group Co Change In Other Working Capital Chart

Sinopharm Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Other Working Capital

Get a 7-Day Free Trial

21,681.24

23,063.21

15,884.61

6,173.92

13,177.30

Sinopharm Group Co Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Other Working Capital	Get a 7-Day Free Trial															12,034.07	24,618.26	-18,444.30	17,931.47	-4,606.40

Sinopharm Group Co Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$13,325 Mil.

Sinopharm Group Co Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Sinopharm Group Co's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinopharm Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinopharm Group Co Ltd (HKSE:01099) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

SHTDY:USA SHTDF:USA X2S:Germany

Address

No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023

Website

http://www.sinopharmgroup.com.cn

Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.

Executives

Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Citic Securities Company Limited	2201 Interest of corporation controlled by you
Zhong Xin Zheng Quan Yun Fan Dan Yi Zi Chan Guan Li Ji Hua	2501 Other
Zhong Xin Zheng Quan Zi Chan Guan Li You Xian Gong Si	2102 Investment manager
Lazard Asset Management Llc	2102 Investment manager
Citigroup Inc.	2502 Approved lending agent
Fmr Llc	2201 Interest of corporation controlled by you
Blackrock, Inc.	2201 Interest of corporation controlled by you

Sinopharm Group Co Headlines

No Headlines